Evaxion A (EVAX) Exchange Rate Effect (2020 - 2022)
Evaxion A's (EVAX) quarterly Exchange Rate Effect came in at -$590000.0 in Q2 2022, down 734.41% YoY from $93000.0 in Q2 2021, and down 293.33% on a QoQ basis from -$150000.0 in Q1 2022.
Evaxion A (EVAX) Exchange Rate Effect (2020 - 2022) Analysis & Trends
Evaxion A (EVAX) has 3 years of Exchange Rate Effect data on file, last reported at -$590000.0 in Q2 2022.
- Quarterly Exchange Rate Effect fell 734.41% year-over-year to -$590000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was -$718000.0 (down 350.17% YoY) and the FY2025 annual result came in at $1.5 million, up 725.68% from the prior year.
- Exchange Rate Effect eased to -$590000.0 in Q2 2022, from -$150000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $231000.0 in Q1 2021 to a low of -$590000.0 in Q2 2022.
- A 3-year average of -$86125.0 and a median of -$65000.0 in 2020 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect soared 257.63% — and 2022, when it sank 734.41%.
- Tracing EVAX's Exchange Rate Effect over 3 years: stood at $22000.0 in 2020, then sank by 422.73% to -$71000.0 in 2021, then sank by 730.99% to -$590000.0 in 2022.
- The last three Exchange Rate Effect figures came in at -$590000.0 (Q2 2022), -$150000.0 (Q1 2022), and -$71000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | - |
| 10 | Evaxion A | 27.77 Mn | 27.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -590,000.00 |
| Jun 30, 2022 | -590,000.00 |
| Mar 31, 2022 | -150,000.00 |
| Mar 31, 2022 | -150,000.00 |
| Sep 30, 2021 | -71,000.00 |
| Sep 30, 2021 | -71,000.00 |
| Jun 30, 2021 | 93,000.00 |
| Jun 30, 2021 | 93,000.00 |
| Mar 31, 2021 | 231,000.00 |
| Mar 31, 2021 | 231,000.00 |
| Sep 30, 2020 | 22,000.00 |
| Sep 30, 2020 | 22,000.00 |
| Jun 30, 2020 | -59,000.00 |
| Jun 30, 2020 | -59,000.00 |
| Mar 31, 2020 | -165,000.00 |
| Mar 31, 2020 | -165,000.00 |